Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

stallergenes ag - niccoli sulfas, alcoholes adipis lanae, neomycini sulfas, kalii dichromas, benzocainum, cinchocaini hydrochloridum, tetracaini hydrochloridum, amylis cinnamaldehydum, isoeugenolum, cinnamaldehydum, eugenolum, alcohol cinnamylicus, hydroxycitronellalum, geraniolum, evernia prunastri, colophonium, e 218, e 214, propylis parahydroxybenzoas, butylis parahydroxybenzoas, benzylis parahydroxybenzoas, balsamum peruvianum, ethylendiamini dihydrochloridum, cobalti dichloridum, resina p-tert-butylphenoli formaldehydi, epoxy resina, diphenylguanidinum, zinci diethyldithiocarbamas, zinci dibutyldithiocarbamas, isopropylphenyl-para-phenylendiaminum, cyclohexylphenyl-para-phenylendiaminum, diphenyl-para-phenylendiaminum, methylchloroisothiazolinonum, methylisothiazolinonum, quaternium-15, methyldibromoglutaronitrilum, para-phenylendiaminum, formaldehydum, morpholinylmercaptobenzothiazolum, cyclohexylbenzothiazylis sulfenamidum, dibenzothiazylis disulfidum, thiomersalum, tetramethylthiuramum monosulfidum, thiramum, disulfiramum, dipentamethylenis thiurami disulfidum, diazolidinylureum, clioquinolum, chlorquinaldolum, tixocortoli pivalas, natrii aurothiosulfas dihydricus, imidazolidinylureum, budesonidum, hydrocortisoni-17 butyras, mercaptobenzothiazolum, bacitracinum, parthenolidum, caeruleum dispersatum 106, bronopolum - patch - tela cum praeparatione (panel 1): niccoli sulfas 0.16 mg, hydroxypropylcellulosum, alcoholes adipis lanae 0.81 mg, povidonum, neomycini sulfas 0.49 mg, povidonum, kalii dichromas 0.044 mg, povidonum, cain-mix: benzocainum 0.364 mg, cinchocaini hydrochloridum 0.073 mg, tetracaini hydrochloridum 0.073 mg, povidonum, parfum-mix: amylis cinnamaldehydum 0.015 mg, isoeugenolum 0.015 mg, cinnamaldehydum 0.034 mg, eugenolum 0.034 mg, alcohol cinnamylicus 0.054 mg, hydroxycitronellalum 0.054 mg, geraniolum 0.070 mg, evernia prunastri 0.070 mg, hydroxypropylcellulosum, betadexum, colophonium 0.97 mg, povidonum, e 320 0.011 mg, e 321 0.011 mg, paraben-mix: e 218 0.16 mg, e 214 0.16 mg, propylis parahydroxybenzoas 0.16 mg, butylis parahydroxybenzoas 0.16 mg, benzylis parahydroxybenzoas 0.16 mg, povidonum, balsamum peruvianum 0.65 mg, povidonum, ethylendiamini dihydrochloridum 0.041 mg, povidonum, cobalti dichloridum 0.016 mg, hydroxypropylcellulosum, polyesterum, ethyleni et vinylis acetatis polymerisatum, acrylic adhesive, pro praeparatione. tela cum praeparatione (panel 2): resina p-tert-butylphenoli formaldehydi 0.036 mg, hydroxypropylcellulosum, epoxy resina 0.041 mg, hydroxypropylcellulosum, carba-mix: diphenylguanidinum 0.068 mg, zinci diethyldithiocarbamas 0.068 mg, zinci dibutyldithiocarbamas 0.068 mg, hydroxypropylcellulosum, schwarzgummi-mix: isopropylphenyl-para-phenylendiaminum 0.010 mg, cyclohexylphenyl-para-phenylendiaminum 0.025 mg, diphenyl-para-phenylendiaminum 0.025 mg, povidonum, methyl(chlor)isothiazolinon: methylchloroisothiazolinonum 0.0024 mg, methylisothiazolinonum 0.00081 mg, povidonum, quaternium-15 0.081 mg, hydroxypropylcellulosum, methyldibromoglutaronitrilum 0.0041 mg, povidonum, para-phenylendiaminum 0.065 mg, povidonum, formaldehydum 0.15 mg ut hydroxymethylis succinimidum, natrii carbonas, natrii hydrogenocarbonas, povidonum, mercapto-mix: morpholinylmercaptobenzothiazolum 0.020 mg, cyclohexylbenzothiazylis sulfenamidum 0.020 mg, dibenzothiazyli - diagnostic de l'allergie - allergène: diagnostic

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

interdelta s.a. - polymyxini b sulfas, neomycini sulfas, dexamethasoni-21 (3-sulfobenzoas) natricus - ohrentropfen - polymyxini b sulfas 10000 u.i., neomycini sulfas 10 mg, dexamethasoni-21 (3-sulfobenzoas) natricus 1 mg, macrogolum 400, conserv.: thiomersalum, excipiens ad solutionem pro 1 ml. - otitis - synthetika human

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

farmaceutica teofarma suisse sa - fluocinonidum, gramicidinum, neomycinum, nystatinum - pommade - fluocinonidum 0.5 mg, gramicidinum 0.25 mg, neomycinum 2.5 mg ut neomycini sulfas, nystatinum 100000 u.i., propyleni carbonas, paraffinum liquidum, alcoholes adipis lanae 5 mg, vaselinum flavum, cera alba, vaselinum album, ad unguentum pro 1 g. - les dermatoses superinfettati par des bactéries et/ou des levures - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

farmaceutica teofarma suisse sa - fluocinonidum, gramicidinum, neomycinum, nystatinum - crème - fluocinonidum 0.5 mg, gramicidinum 0.25 mg, neomycinum 3.5 mg ut neomycini sulfas, nystatinum 100000 u.i., propylenglycolum 150 mg, alcohol cetylicus 40 mg, alcohol stearylicus 70 mg, sorbitani stearas, polysorbatum 60, paraffinum liquidum, acidum citricum, aqua purificata, propylis parahydroxybenzoas 0.5 mg, e 218 1.8 mg, ad unguentum pro 1 g. - les dermatoses superinfettati par des bactéries et/ou des levures - synthetika

Belgique - français - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

huvepharma sa-nv - sulfate de néomycine - eq. néomycine 100 mg/10 ml; chlorhydrate de lincomycine - eq. lincomycine 330 mg/10 ml - solution intramammaire - 10 mg/ml - 33 mg/ml - chlorhydrate de lincomycine; sulfate de néomycine - lincomycin - bovin

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

farmaceutica teofarma suisse sa - fluocinoloni acetonidum, neomycinum - crème - fluocinoloni acetonidum 0,25 mg, neomycinum 3,5 mg de neomycini sulfamidés, propylenglycolum, conserv.: e 216, e 218, excipiens ad pommade pour 1 g de la. - dermatoses inflammatoires ou allergiques, surinfectées par des bactéries - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

farmaceutica teofarma suisse sa - fluocinoloni acetonidum, neomycinum - pommade - fluocinoloni acetonidum 0,25 mg, neomycinum 3,5 mg de neomycini sulfamidés, propylenglycolum, de graisse avec du, excipiens ad pommade pour 1 g de la. - dermatoses inflammatoires ou allergiques, surinfectées par des bactéries - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - fluocinonidum, gramicidinum, neomycinum, nystatinum - onguent - fluocinonidum 0,5 mg, gramicidinum 0,25 mg, neomycinum 2,5 mg à neomycini sulfamidés, nystatinum 100000 u. i., alcoholes notre nouveau avec, excipiens ad pommade pour 1 g de la. - dermatoses surinfectées par des bactéries et/ou des levures - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - fluocinonidum, gramicidinum, neomycinum, nystatinum - crème - fluocinonidum 0,5 mg, gramicidinum 0,25 mg, neomycinum 3,5 mg de neomycini sulfamidés, nystatinum 100000 u. i., propylenglycolum, conserv.: propylis parahydroxybenzoas, e 218, excipiens ad pommade pour 1 g de la. - dermatoses surinfectées par des bactéries et/ou des levures - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

glaxosmithkline ag - toxoidum diphtheriae, toxoidum tetani, toxoidum pertussis, haemagglutininum filamentosum (b. pertussis), pertactinum (b. pertussis), virus poliomyelitis typus 1 inactivatus (stamm mahoney), virus poliomyelitis typus 2 inactivatus (stamm mef-1), virus poliomyelitis typus 3 inactivatus (stamm saukett), hepatitidis b viri antigenum adnr, polysaccharida haemophili influenzae typus b 20752 conjugata cum toxoido tetani - pulver und suspension zur herstellung einer injektionssuspension - i) dtpa-hepb-ipv: toxoidum diphtheriae min. 30 u.i., toxoidum tetani min. 40 u.i., toxoidum pertussis 25 µg, haemagglutininum filamentosum (b. pertussis) 25 µg, pertactinum (b. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (stamm mahoney) 40 u.i., virus poliomyelitis typus 2 inactivatus (stamm mef-1) 8 u.i., virus poliomyelitis typus 3 inactivatus (stamm saukett) 32 u.i., hepatitidis b viri antigenum adnr 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, aluminium 0.2 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.8 mg, medium 199, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini b sulfas, formaldehydum, polysorbatum 20, polysorbatum 80. ii) hib: polysaccharida haemophili influenzae typus b 20752 conjugata cum toxoido tetani 10 µg, lactosum, aluminium 0.12 mg ut aluminii phosphas, pro praeparatione. i) et ii) corresp. dtpa-hepb-ipv + hib: toxoidum diphtheriae min. 30 u.i., toxoidum tetani min. 40 u.i., toxoidum pertussis 25 µg, haemagglutininum filamentosum (b. pertussis) 25 µg, pertactinum (b. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (stamm mahoney) 40 u.i., virus poliomyelitis typus 2 inactivatus (stamm mef-1) 8 u.i., virus poliomyelitis typus 3 inactivatus (stamm saukett) 32 u.i., hepatitidis b viri antigenum adnr 10 µg, polysaccharida haemophili influenzae typus b 20752 conjugata cum toxoido tetani 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, aluminium 0.32 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.8 mg, medium 199, lactosum, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini b sulfas, formaldehydum, polysorbatum 20, polysorbatum 80. - - vaccination et rappel contre la diphtérie, le tétanos, la coqueluche, l'hépatite b, la poliomyélite et haemophilus influenzae de type b, à partir de l'âge de 6. semaine de vie - les vaccins